Xanthopsia - Causes, Treatment & When to See a Doctor

What is Xanthopsia?

Xanthopsia (from Greek xanthos “yellow” and opsis “vision”) is a visual disturbance in which objects appear tinted yellow or amber. The condition is a type of chromatic aberration—a change in color perception—rather than a true change in the color of the objects themselves. Xanthopsia can be transient (lasting seconds to minutes) or persistent (lasting days, weeks, or longer) depending on the underlying cause.

People with xanthopsia may report that white paper looks creamy, a clear sky appears hazy, or that everyday items have a “golden” hue. The phenomenon is often subtle at first and may be mistaken for lighting changes, but when it occurs without an obvious external cause, it warrants further evaluation.

Understanding why the visual system starts to favor the yellow end of the spectrum helps clinicians pinpoint neurological, ophthalmic, or systemic problems that may be life‑threatening.

Common Causes

Xanthopsia is not a disease itself; it is a symptom that can result from a wide range of conditions. The most frequently reported causes include:

• Medications – especially digoxin, quinine, chloroquine, and some antipsychotics (e.g., chlorpromazine).
• Retinal disorders – macular degeneration, central serous chorioretinopathy, and retinitis pigmentosa can alter cone function.
• Cataracts – advanced nuclear sclerosis often gives a yellow‑brown cast to vision.
• Diabetes mellitus – fluctuating blood glucose can change lens refractivity and affect color perception.
• Neurological disease – stroke or lesion involving the visual cortex (particularly the V4 area), migraine aura, or multiple sclerosis.
• Head trauma – diffuse axonal injury or contusion of the occipital lobes may produce chromatic disturbances.
• Systemic toxicity – lead poisoning, carbon monoxide exposure, or severe jaundice (bilirubin deposition in the retina).
• Vitamin A deficiency or excess – both can disrupt photoreceptor function.
• Age‑related changes – natural yellowing of the crystalline lens over decades.
• Psychiatric conditions – rare cases of hallucinogenic drug use (e.g., LSD, mescaline) produce vivid color shifts including yellow.

Associated Symptoms

The presence of additional visual or systemic signs helps narrow the differential diagnosis. Common co‑occurring symptoms include:

• Blurred or hazy vision
• Glare or halos around lights
• Difficulty distinguishing whites from off‑whites (e.g., “yellow‑white” confusion)
• Photophobia (light sensitivity)
• Headache, especially with migraine aura
• Floating spots, flashes, or “curtains” (suggesting retinal detachment)
• Eye pain or redness (possible uveitis or infection)
• Systemic signs such as fatigue, palpitations, or nausea when medication‑related
• Neurological deficits – weakness, speech changes, or facial droop (stroke warning)

When to See a Doctor

While occasional color shifts can be benign, you should schedule an appointment promptly if any of the following occur:

• Sudden onset of yellow vision, especially if it affects one eye only.
• Persistent yellow tint lasting more than 24 hours.
• Accompanying headache, confusion, or loss of coordination.
• Eye pain, redness, or discharge.
• Recent changes in medication dose (e.g., starting or increasing digoxin).
• History of diabetes, hypertension, or cardiovascular disease.
• Any symptom suggestive of stroke or transient ischemic attack (TIA).

Diagnosis

Evaluation of xanthopsia involves a systematic approach that combines a detailed history, eye examination, and targeted investigations.

1. Clinical History

• Medication review – dose, duration, recent changes.
• Systemic illnesses – diabetes, liver disease, exposure to toxins.
• Onset and pattern – sudden vs. gradual, unilateral vs. bilateral.
• Associated visual phenomena – flashes, floaters, scotomas.

2. Comprehensive Eye Exam

• Visual acuity testing with a Snellen chart.
• Color vision testing – Farnsworth‑Munsell 100 Hue test or Ishihara plates can detect selective loss of blue‑green cones that manifests as yellow bias.
• Slit‑lamp biomicroscopy – evaluates lens opacities (cataract) and corneal health.
• Fundoscopy – looks for retinal disease, macular edema, or optic nerve abnormalities.
• Intra‑ocular pressure – rules out glaucoma‑related visual changes.

3. Ancillary Tests

• Optical coherence tomography (OCT) – cross‑sectional imaging of retina and macula.
• Fluorescein angiography – assesses retinal circulation if vascular disease is suspected.
• Visual field testing – distinguishes diffuse color shift from localized scotomas.
• Blood work – CBC, serum electrolytes, liver function, fasting glucose, HbA1c, and toxicology screen when indicated.
• Neuroimaging – MRI of the brain/orbit if neurological cause (stroke, tumor) is in the differential.

Treatment Options

Treatment targets the underlying cause; there is no “eye drops for yellow vision.” Management strategies include:

Medication‑Related Xanthopsia

• Adjust dosage or discontinue the offending drug under physician supervision (e.g., reduce digoxin dose).
• Switch to alternative agents when feasible.

Ocular Causes

• Cataract surgery – removal of the yellowed lens restores normal color perception.
• Retinal disease treatment – anti‑VEGF injections for macular edema, laser photocoagulation for central serous chorioretinopathy, or vitamin A supplementation for deficiency.

Systemic and Neurological Causes

• Control blood glucose and blood pressure to prevent diabetic or hypertensive retinopathy.
• Acute stroke management – thrombolysis or thrombectomy when indicated (within therapeutic windows).
• Manage toxin exposure – chelation therapy for lead, supplemental oxygen for carbon monoxide poisoning.
• Address vitamin imbalances – oral vitamin A or beta‑carotene as directed.

Supportive & Home Measures

• Maintain good lighting; use neutral white bulbs (4000 K) to reduce color distortion.
• Wear sunglasses with UV protection outdoors to lessen glare.
• Stay hydrated and keep blood glucose stable with regular meals.
• Adopt a diet rich in antioxidants (leafy greens, berries) that support retinal health.

Prevention Tips

While not all causes are preventable, many risk factors are modifiable:

• Medication vigilance – keep an updated list of prescriptions and discuss visual side effects with your pharmacist.
• Regular eye exams – at least once every two years for adults, and annually for diabetics or those over 60.
• Control chronic diseases – maintain target HbA1c < 7 % and blood pressure < 130/80 mmHg.
• Protect against toxins – avoid lead‑based paints, ensure proper ventilation when using solvents, and install carbon monoxide detectors.
• Healthy lifestyle – balanced diet, regular exercise, and avoiding smoking reduce cataract formation and retinal degeneration.
• Eye safety – wear protective eyewear during sports or work with hazardous material.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (call 911 or go to the nearest emergency department) immediately:

• Sudden, severe loss of vision in one or both eyes.
• Accompanying neurological deficits such as facial droop, weakness, slurred speech, or confusion.
• Sudden onset of severe headache with visual changes (possible stroke or intracranial bleed).
• Eye pain with redness, swelling, or discharge suggestive of acute uveitis or infection.
• Trauma to the head or eye followed by color distortion.
• Palpitations, chest pain, or shortness of breath with yellow vision while on digoxin (possible toxicity).

---

**References**

1. Mayo Clinic. “Digoxin side effects.” Mayo Clinic, 2023. Link
2. American Academy of Ophthalmology. “Cataract.” AAO, 2022. Link
3. National Institute of Diabetes and Digestive and Kidney Diseases. “Diabetic Retinopathy.” NIH, 2024. Link
4. World Health Organization. “Lead poisoning.” WHO, 2023. Link
5. Cleveland Clinic. “Migraine with aura.” Cleveland Clinic, 2023. Link
6. National Eye Institute. “Age‑Related Macular Degeneration.” NEI, 2024. Link
7. CDC. “Carbon Monoxide Poisoning.” Centers for Disease Control and Prevention, 2022. Link
8. Harvey, R. et al. “Color vision changes in digoxin toxicity.” JAMA Ophthalmology, 2021;139(5):562‑568. DOI:10.1001/jamaophthalmol.2021.0234